Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 23, 2024 15:29 ET | Source: Portnoy Law

MacroGenics, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. September 24, 2024 Deadline to file Lead Plaintiff Motion

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Sept. 23, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises MacroGenics, Inc....
September 11, 2024 14:50 ET | Source: Robbins LLP

Lead Plaintiff Deadline Quickly Approaching in MacroGenics, Inc. (MGNX) Class Action – Shareholders Should Contact Robbins LLP for Information

Robbins LLP is Investigating Allegations that MacroGenics, Inc. (MGNX) Misled Investors Regarding the Viability of its Drug Candidate
August 30, 2024 15:20 ET | Source: Portnoy Law

MacroGenics, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. September 24, 2024 Deadline to file Lead Plaintiff Motion.

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Aug. 30, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises MacroGenics, Inc....
August 20, 2024 16:47 ET | Source: Robbins LLP

Robbins LLP Reminds MacroGenics, Inc. (MGNXX) Investors of the Class Action Lawsuit and Pending Lead Plaintiff Deadline

Robbins LLP is Investigating Allegations that MacroGenics, Inc. (MGNX) Misled Investors Regarding the Viability of its Drug Candidate
August 07, 2024 16:31 ET | Source: Robbins LLP

MacroGenics, Inc. Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Against MGNX

Robbins LLP is Investigating Allegations that MacroGenics, Inc. (MGNX) Misled Investors Regarding the Viability of its Drug Candidate
July 30, 2024 22:18 ET | Source: Robbins LLP

Shareholder Alert: Robbins LLP Informs Investors of the Class Action Filed Against MacroGenics, Inc. (MGNX)

Robbins LLP is Investigating Allegations that MacroGenics, Inc. (MGNX) Misled Investors Regarding the Viability of its Drug Candidate
July 29, 2024 11:39 ET | Source: Block & Leviton LLP

MacroGenics ALERT: Securities Fraud Lawsuit Could Allow Investors to Recover Losses; Block & Leviton Encourages Investors to Contact the Firm to Learn More

Block & Leviton announces that a securities fraud lawsuit has been filed against MacroGenics, Inc. (NASDAQ: MGNX) and certain of its executives.
June 24, 2024 15:13 ET | Source: Portnoy Law

MacroGenics, Inc. Investors: Company Investigated by the Portnoy Law Firm

LOS ANGELES, June 24, 2024 (GLOBE NEWSWIRE) -- Investors can contact the law firm at no cost to learn more about recovering their losses The Portnoy Law Firm advises MacroGenics, Inc....
June 17, 2021 14:49 ET | Source: Portnoy Law

MacroGenics, Inc. Investors: Company Investigated by the Portnoy Law Firm

LOS ANGELES, June 17, 2021 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises MacroGenics, Inc. ("MacroGenics" or the "Company") (NASDAQ: MGNX) investors that the firm has initiated an investigation...